571P Real-life monocentric, retrospective study on efficacy and tolerability of lenvatinib (Len) in patients (pts) with advanced radioactive iodine–refractory differentiated thyroid cancer (rDTC)

• DOI: 10.1016/j.annonc.2021.08.706
• Publication Date: 2021-09-21T14:49:16Z
• Authors: S. Zovato; S. Watutantrige; A.M. Ferrara; E. Mioranza; M.G. Ghi; S. Tognazzo; F. Schiavi; E. taschin; G. Doria; A. Rastelli; A. Di Marco; G. Magni; G. Crivellari
• Keywords: Lenvatinib; Tolerability; Refractory (planetary science)